(Reuters) – A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission’s efforts to unwind the multi-billion-dollar deal, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
The FTC had sought to stop Illumina’s $7.1 billion proposed acquisition of cancer detection test maker Grail, alleging it would harm innovation and boost prices.
Illumina and Grail did not immediately respond to Reuters requests for comment.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shounak Dasgupta)
